“…TAB2 [131], CCR4 [112], LTF (lactotransferrin) [126], hsa-mir-146a-5p [613], hsa-mir-8485 [614], BRCA1 [615], NFKB1 [616], TEAD1 [617], TFAP2C [618], FOXO3 [619 and NRF1 [620] risk factors have been shown to increase susceptibility to cardiovascular diseases. Several studies have shown that TAB2 [131], LTF (lactotransferrin) [487], BRCA1 [621], NFKB1 [622], TEAD1 [623], FOXO3 [624] and NRF1 [625] can be involved in the disease progression of obesity ., Altered expression of CCR4 [280], LTF (lactotransferrin) [295], CDH1 [313], CFTR (CF transmembrane conductance regulator) [317], hsa-mir-146a-5p [626], hsa-mir-195-5p [627], hsa-mir-4739 [628], HNF4A [629], NFKB1 [630], NR2F1 [631], FOXO3 [632] and NRF1 [633] are observed in diabetes mellitus. CCR4 [407], hsa-mir-146a-5p [634] and NFKB1 [635] were associated with psychiatric disorders.…”